NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Anokion

Private
EcublensHealthcare & Life Sciences

Last Round

Corporate Funding

Oct 18, 2022

Total Funding Raised

$112.5M

Company Overview

Anokion is a biotechnology company that develops antigen-specific immunotherapy aimed at promoting immune tolerance for various autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

immune toleranceautoimmune therapybiotechnologyantigen-specific therapyclinical-stage biotechdrug discoveryimmunologytherapeutic platformclinical trialsbiopharma partnershipimmune modulationtolerogenic therapynext-gen immunologyliver-targeted therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anokion Comparables

Compare Anokion with similar companies based on industry and business-model similarity.

Anokion comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Parvus Therapeutics Inc.
87%
Worg Pharmaceuticals
83%
AnTolRx, Inc.
83%

Anokion Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingOct 18, 2022
Series BSep 11, 2019
Series AMay 5, 2014

Anokion Investors

Notable investors and investment history

Anokion investors
InvestorRounds
Novo VenturesSeries B, Series A
Versant VenturesSeries B, Series A
Novo HoldingsSeries B, Series A
PfizerCorporate Funding

Anokion Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Anokion Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Anokion's valuation, stock price, and market status.

Firmographic Details

HeadquartersEcublens
Employee Range14
Year Founded2010
Last FundingOct 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.